GUIDED THERAPEUTICS INC Quarterly Common Stock, Shares Authorized from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Guided Therapeutics Inc quarterly Common Stock, Shares Authorized history and growth rate from Q4 2010 to Q2 2024.
  • Guided Therapeutics Inc Common Stock, Shares Authorized for the quarter ending June 30, 2024 was 500M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 500M 0 0% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 500M 0 0% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 500M 0 0% Dec 31, 2023 10-Q 2024-08-14
Q3 2023 500M 0 0% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 500M 0 0% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 500M 0 0% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 500M 0 0% Dec 31, 2022 10-K 2024-03-28
Q3 2022 500M -2.5B Sep 30, 2022 10-Q 2022-11-14
Q2 2022 500M +497M +16567% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 500M +497M +16567% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 500M 0 0% Dec 31, 2021 10-K 2023-03-30
Q3 2021 3B* +3B Sep 30, 2021 10-Q 2021-11-15
Q2 2021 3M 0 0% Jun 30, 2021 10-Q 2021-08-18
Q1 2021 3M 0 0% Mar 31, 2021 10-Q/A 2021-08-18
Q4 2020 500M +497M +16567% Dec 31, 2020 10-K 2022-03-30
Q3 2020 3M +2M +200% Sep 30, 2020 10-Q/A 2020-11-05
Q2 2020 3M +2M +200% Jun 30, 2020 10-Q 2020-08-20
Q1 2020 3M +2M +200% Mar 31, 2020 10-Q 2020-07-07
Q4 2019 3M 0 0% Dec 31, 2019 10-K 2021-04-07
Q3 2019 1M 0 0% Sep 30, 2019 10-Q 2020-03-09
Q2 2019 1M 0 0% Jun 30, 2019 10-Q 2020-02-11
Q1 2019 1M 0 0% Mar 31, 2019 10-Q 2019-07-11
Q4 2018 3M +2M +200% Dec 31, 2018 10-K 2020-04-20
Q3 2018 1M 0 0% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 1M 0 0% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 1M 0 0% Mar 31, 2018 10-Q 2018-05-21
Q4 2017 1M 0 0% Dec 31, 2017 10-K 2019-05-08
Q3 2017 1M 0 0% Sep 30, 2017 10-Q 2017-11-20
Q2 2017 1M 0 0% Jun 30, 2017 10-Q 2017-08-18
Q1 2017 1M 0 0% Mar 31, 2017 10-Q 2017-05-22
Q4 2016 1M 0 0% Dec 31, 2016 10-K/A 2018-04-20
Q3 2016 1M +805K +413% Sep 30, 2016 10-Q 2016-12-05
Q2 2016 1M +755K +308% Jun 30, 2016 10-Q 2016-08-17
Q1 2016 1M +805K +413% Mar 31, 2016 10-Q 2016-05-19
Q4 2015 1M +805K +413% Dec 31, 2015 10-K 2017-03-22
Q3 2015 195K -145M -99.9% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 245K -145M -99.8% Jun 30, 2015 10-Q 2015-08-13
Q1 2015 195K +50K +34.5% Mar 31, 2015 10-Q 2015-05-13
Q4 2014 195K +50K +34.5% Dec 31, 2014 10-K 2016-03-15
Q3 2014 145M +145M +99900% Sep 30, 2014 10-Q 2014-11-12
Q2 2014 145M +145M +99900% Jun 30, 2014 10-Q 2014-08-13
Q1 2014 145K 0 0% Mar 31, 2014 10-Q 2014-05-15
Q4 2013 145K 0 0% Dec 31, 2013 10-K 2015-03-25
Q3 2013 145K 0 0% Sep 30, 2013 10-Q 2013-11-13
Q2 2013 145K +45K +45% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 145K +45K +45% Mar 31, 2013 10-Q 2013-05-14
Q4 2012 145K +45K +45% Dec 31, 2012 10-K 2014-03-26
Q3 2012 145K Sep 30, 2012 10-Q 2012-11-13
Q2 2012 100K 0 0% Jun 30, 2012 10-Q/A 2012-08-24
Q1 2012 100K Mar 31, 2012 10-Q 2012-05-14
Q4 2011 100K 0 0% Dec 31, 2011 10-K 2013-03-27
Q2 2011 100K Jun 30, 2011 10-Q 2011-11-14
Q4 2010 100K Dec 31, 2010 10-K 2012-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.